CME Group and Nasdaq Extend Exclusive Nasdaq-100 Futures License Through 2039
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Bel Fuse acquires dataMate ethernet business for $16 million
Nasdaq OMX Group Inc. (NDAQ) PT Raised to $99 at Raymond James, 'Firing on All Cylinders'
July 24, 2025 11:30 AM EDTRaymond James analyst Patrick O\'Shaughnessy raised the price target on Nasdaq OMX Group Inc. (NASDAQ: NDAQ) to $99.00 (from $96.00) while maintaining a Outperform rating.
The analyst comments "We maintain our Outperform rating on Nasdaq following the release of 2Q25 earnings and increase our... More
Raymond James Reiterates Outperform Rating on Nasdaq OMX Group Inc. (NDAQ)
July 24, 2025 8:13 AM EDTRaymond James analyst Patrick O\'Shaughnessy reiterated an Outperform rating and $96.00 price target on Nasdaq OMX Group Inc. (NASDAQ: NDAQ).
The analyst comments "Nasdaq posted strong results in the second quarter with each segment finishing ahead of expectations. Total organic revenue growth of... More
Citi Reiterates Neutral Rating on Nasdaq OMX Group Inc. (NDAQ)
July 24, 2025 8:11 AM EDTCiti analyst Chris Allen reiterated a Neutral rating and $95.00 price target on Nasdaq OMX Group Inc. (NASDAQ: NDAQ).
The analyst comments "NDAQ reported 2Q25 adj. EPS of $0.85 (vs our/Factset consensus est. of $0.83/0.81). Relative to our estimates, net revenue was above our... More
CME Group (CME) PT Raised to $309 at Raymond James
July 23, 2025 12:18 PM EDTRaymond James analyst Patrick O\\\'Shaughnessy raised the price target on CME Group (NASDAQ: CME) to $309.00 (from $306.00) while maintaining a Outperform rating.
The analyst comments "We maintain our Outperform rating on CME Group following 2Q25 earnings and bump our target... More
